Common Health Coalition

News

The OpenAI Foundation has committed $100m to help fund a new public health initiative initially focused on hepatitis C.

News

Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.